Laura Spring

Trials

Studies that name Laura Spring as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:00 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04230109 · Sacituzumab Govitecan In TNBC

  Massachusetts General Hospital · recruiting · Invasive Breast Cancer, Triple Negative Breast Cancer, ER-Negative Breast Cancer · principal investigator
• Ph1/Ph2
  NCT04039230 · Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.

  Massachusetts General Hospital · active not recruiting · Breast Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.